Utility of the Red Blood Cell-Derived Microparticles as a Marker of Periprocedural Adverse Effects amongst Patients with Acute ST-Segment Elevation Myocardial Infarction

Alexander E Berezin
  • Journal of Vascular Medicine & Surgery, January 2016, OMICS Publishing Group
  • DOI: 10.4172/2329-6925.1000295
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Professor Alexander E Berezin